In HCC patients, the homeostatic balance of CD226, TIGIT, and CD96 expression on NK cells is disrupted, characterized by significant up-regulation of CD96, which strongly correlates with elevated TGF-β1 levels in the TME. The gene discussed is CD96; the disease is hepatocellular carcinoma.